i pleased acknowledged recent story st paul pioneer press reporter jeremy olson wrote following story internet psychiatry blog first raised questions march research schulz presented apa conference lacked company findings raises troubling questions independent academic author presents results direct opposition underlying data wrote blogger anonymous academic cite blog name unwieldy long name i stupidly chose site may responsible i nonetheless grateful site acknowledged work story referencing post i noted university minnesota psychiatry professor charles schulz stated press release seroquel effective haldol based upon analysis data comparing seroquel much older antipsychotic drug haldol treatment schizophrenia yet internal astrazeneca analysis found haldol actually effective seroquel pioneer press star tribune two big papers minneapolis st paul area ran stories controversy asked lavishing praise seroquel press release pioneer press said interview pioneer press last week schulz defended research presentation seroquel accurate ethical however acknowledged corporate press release apa presentation might exaggerated calling seroquel significantly superior know said i ca disagree schulz said following star tribune interview week schulz said pharmaceutical company never shared doubts seroquel went become blockbuster annual sales billion today i recall anybody calling saying oh goodness problem said time schulz acknowledged study really show seroquel effective older drug bit misunderstanding said i think overall message works thanks helpful reader i able track appears schulz presentation says quetiapine clearly statistically significantly superior placebo well haloperidol appears contradict statement haldol seroquel work data schulz presentation match astrazeneca internal analysis schulz obviously backing away earlier praise seroquel deserves credit problem schulz along laundry list researchers psychiatry caught tidal wave unbridled enthusiasm atypical antipsychotics first wonder drugs schizophrenia next big thing bipolar moving world depression anxiety disorders absence decent supportive evidence interesting sidenote schulz presenting wonders seroquel likely quite unaware astrazeneca conducted study study found seroquel compared unfavorably haldol preventing psychotic relapse among patients schizophrenia began study full partial symptom remisison furious seasons additional reporting study near certainty schulz informed study results could changed lofty opinion seroquel points problem researchers relying data collected drug companies researchers know receiving data note key opinion leaders realize pawns used place academic veneer marketing drugs drugs marketing major breakthroughs typically offer little benefit existing treatment may cause slew nasty side effects decide want scientist marketer try time odds pretty good scientific credentials end tarnished ask guy media paying much closer attention conflicted interests skewed science sadly underlie much psychiatry days would good idea maintain appearances